Zhen-Jian Zhuo 1 , 11 , Rui-Xi Hua 1 , 2 , 11 , Zhen Chen 3 , 11 , Jinhong Zhu 1 , 4 , Mi Wang 1 , Zhonghua Yang 5 , Jiao Zhang 6 , Yong Li 7 , Li Li 8 , Suhong Li 9 , Yijuan Xin 10 , Huimin Xia 1 , ∗∗ , Jing He 1 , ∗
09 June 2020
Hepatoblastoma is a rare disease, and its etiology remains to be revealed. Wilms tumor suppressor-1-associated protein (WTAP) plays a critical role in tumorigenesis. However, whether single nucleotide polymorphisms (SNPs) of the WTAP gene predispose to hepatoblastoma risk awaits to be investigated. With the use of the TaqMan assay, we evaluated the genotype frequencies of three WTAP SNPs (rs7766006 G > T, rs9457712 G > A, and rs1853259 A > G) in Chinese children with 313 hepatoblastoma patients and 1,446 controls. Among these three SNPs, only the rs7766006 T allele exhibited a significant association with hepatoblastoma risk (GT versus GG: adjusted odds ratio [OR] = 0.70, 95% confidence interval [CI] = 0.53–0.92, p = 0.009; GT/TT versus GG: adjusted OR = 0.73, 95% CI = 0.57–0.95, p = 0.017). Combined analysis indicated that subjects with two risk genotypes showed significantly higher hepatoblastoma risk, compared to individuals without a risk genotype (adjusted OR = 1.38, 95% CI = 1.02–1.88, p = 0.037). The stratified analysis revealed that the rs1853259 GG genotype, the rs7766006 GT/TT genotype, and two risk genotypes modified hepatoblastoma risk in certain subgroups. The significant results were validated by haplotype analyses and false-positive report probability analyses. Furthermore, the expression quantitative trait locus analysis indicated that rs7766006 T was associated with decreased expression of WTAP mRNA. Collectively, our results suggest that WTAP SNPs may be genetic modifiers for the development of hepatoblastoma.
The role of WTAP gene SNPs in hepatoblastoma remains to be elucidated. He and colleagues showed that the WTAP gene rs7766006 T allele exhibited a significant association with hepatoblastoma risk, possibly by decreasing expression of WTAP mRNA. Their work suggests that WTAP gene SNPs may be genetic modifiers for hepatoblastoma susceptibility.